Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening (Q36745822)

16 August 2017

Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening (English)

1 reference

colorectal cancer screening

16 August 2017

0 references

1 reference

1 reference

1 reference

Marjolein van Ballegooijen

inferred from title

author

series ordinal

9

object named as

Marjolein van Ballegooijen

1 reference

16 August 2017

Iris Lansdorp-Vogelaar

series ordinal

5

object named as

Iris Lansdorp-Vogelaar

1 reference

16 August 2017

7

Ernst J Kuipers

1 reference

16 August 2017

8

Monique E van Leerdam

1 reference

16 August 2017

1

S Lucas Goede

1 reference

16 August 2017

4

Anneke J van Vuuren

1 reference

16 August 2017

2

Aafke H C van Roon

1 reference

Jacqueline C I Y Reijerink

16 August 2017

series ordinal

3

object named as

Jacqueline C I Y Reijerink

1 reference

16 August 2017

J Dik F Habbema

6

1 reference

16 August 2017

language of work or name

English

0 references

publication date

5 April 2012

1 reference

16 August 2017

1 reference

16 August 2017

62

1 reference

16 August 2017

5

1 reference

16 August 2017

727-734

1 reference

16 August 2017

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618685

Trends in colorectal cancer in the south of the Netherlands 1975-2007: rectal cancer survival levels with colon cancer survival

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618685

Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618685

The impact of healthcare costs in the last year of life and in all life years gained on the cost-effectiveness of cancer screening

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618685

Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618685

A novel hypothesis on the sensitivity of the fecal occult blood test: Results of a joint analysis of 3 randomized controlled trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618685

Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618685

The UK colorectal cancer screening pilot: results of the second round of screening in England

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618685

Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618685

Polyp miss rate determined by tandem colonoscopy: a systematic review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618685

National Polyp Study data: evidence for regression of adenomas

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618685

High compliance rates observed for follow up colonoscopy post polypectomy are achievable outside of clinical trials: efficacy of polypectomy is not reduced by low compliance for follow up.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618685

A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618685

Quality of life in survivors of colorectal carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618685

Utility valuations for outcome states of colorectal cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618685

Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618685

Randomised controlled trial of faecal-occult-blood screening for colorectal cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618685

Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618685

President's address. The polyp-cancer sequence in the large bowel

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618685

Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618685

Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618685

Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618685

Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618685

Cost of care for elderly cancer patients in the United States.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618685

Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3618685

[Revised CBO guideline 'Follow-up after polypectomy']

5 September 2018

1 reference

12 December 2020

The evolution of cancer of the colon and rectum

1 reference

12 December 2020

The MISCAN-COLON Simulation Model for the Evaluation of Colorectal Cancer Screening

1 reference

12 December 2020

Colonoscopic evaluation of immunochemical fecal occult blood test for detection of colorectal neoplasia

1 reference

12 December 2020

How much can current interventions reduce colorectal cancer mortality in the U.S.?

1 reference

12 December 2020

Screening for colorectal cancer in Italy: 2005 survey

1 reference

12 December 2020

Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population

1 reference

12 December 2020

Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy

1 reference

12 December 2020

Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening

1 reference

12 December 2020

Cost-Effectiveness of Mass Screening for Colorectal Cancer: Choice of Fecal Occult Blood Test and Screening Strategy

1 reference

12 December 2020

Cost-effectiveness analysis of immunochemical occult blood screening for colorectal cancer among three fecal sampling methods

1 reference

12 December 2020

10.1136/GUTJNL-2011-301917

Identifiers

DOI

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

22490518

1 reference